Manufacturer record

RK Life Care INC: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by RK Life Care INC (Haryana) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: RKCXBP003, Ceftriaxone Injection IP 1000 mg (exp Dec 2027). ALIGARH, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to I.P. in the respect of Clarity of solution, Particulate matter and misbranded with labelling. Listed in the September 2026 alert.

Records by type

1 record linked to RK Life Care INC in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2026
1
Products affected
Particulate matter
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ceftriaxone Injection IP 1000 mg Batch RKCXBP003Mfg Jan 2026 · Exp Dec 2027 The sample does not conform to I.P. in the respect of Clarity of solution, Particulate matter and misbranded with labellingParticulate matter ALIGARH, Uttar PradeshState lab Sep 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.